Grant: Discovery Grants Program - Individual
University of Guelph
$36,000.00
Polysaccharide Discovery and Synthesis
EF 2017-18
Résumé
Complex polysaccharides are key components of bacterial surfaces that may be used as serotype markers and vaccine antigens. The backbone of our research program is the structural chemistry of novel bacterial polysaccharides and their syntheses. The polysaccharide structures are elucidated using a physico-chemical approach based on chemical manipulations, analytical and spectroscopic studies. Nowadays, data generated by state-of-the-art nuclear magnetic resonance spectroscopy and mass spectrometry yield fine structural information and are thus indispensable tools in our polysaccharide program. Although we base our initial plans on the typical framework of carbohydrate structures, each polysaccharide ultimately requires that specific approaches be devised in order for its fine structure to be characterized. In particular, microbes possess the ability to elaborate complex polysaccharides often containing previously unknown sugars. Accordingly, the exploration of new methodologies for polysaccharide analysis is a component of our program. Our structural findings are the foundation for subsequent studies (by us and others) that deal with microbial polysaccharide syntheses, genetics, biological functions and vaccine design. Our research program concentrates on pathogenic gastro-intestinal bacteria, especially those involved with the onset of diarrhea in humans. Polysaccharides exposed by Campylobacter jejuni (traveller's diarrhea) and Clostridium difficile (antibiotic-associated diarrhea) have been discovered in our lab in the past decade and are now the key ingredients in our prototype conjugate vaccines that are undergoing pre-clinical and human trials in industrial and government agencies. Structural and synthetic studies involving C. jejuni and C. difficile surface carbohydrates will continue to be part of our proposed program, but new polysaccharide targets from microbes associated with autism-associated gut ailments (Desulfovibrio and Sutterella species) and colorectal cancer-causing bacteria (Fusobacterium) will become part of our research in the coming years.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2016-04472
Name nom
Monteiro, Mario
Department département
Chemistry - Chemistry
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2016
Award amount
36000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
3702
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Carbohydrates
Research subject fr
Glucides
Partie
2
Nb partie
5
Application title
Polysaccharide Discovery and Synthesis
Keyword
NSERC
Application summary
Complex polysaccharides are key components of bacterial surfaces that may be used as serotype markers and vaccine antigens. The backbone of our research program is the structural chemistry of novel bacterial polysaccharides and their syntheses. The polysaccharide structures are elucidated using a physico-chemical approach based on chemical manipulations, analytical and spectroscopic studies. Nowadays, data generated by state-of-the-art nuclear magnetic resonance spectroscopy and mass spectrometry yield fine structural information and are thus indispensable tools in our polysaccharide program. Although we base our initial plans on the typical framework of carbohydrate structures, each polysaccharide ultimately requires that specific approaches be devised in order for its fine structure to be characterized. In particular, microbes possess the ability to elaborate complex polysaccharides often containing previously unknown sugars. Accordingly, the exploration of new methodologies for polysaccharide analysis is a component of our program. Our structural findings are the foundation for subsequent studies (by us and others) that deal with microbial polysaccharide syntheses, genetics, biological functions and vaccine design. Our research program concentrates on pathogenic gastro-intestinal bacteria, especially those involved with the onset of diarrhea in humans. Polysaccharides exposed by Campylobacter jejuni (traveller's diarrhea) and Clostridium difficile (antibiotic-associated diarrhea) have been discovered in our lab in the past decade and are now the key ingredients in our prototype conjugate vaccines that are undergoing pre-clinical and human trials in industrial and government agencies. Structural and synthetic studies involving C. jejuni and C. difficile surface carbohydrates will continue to be part of our proposed program, but new polysaccharide targets from microbes associated with autism-associated gut ailments (Desulfovibrio and Sutterella species) and colorectal cancer-causing bacteria (Fusobacterium) will become part of our research in the coming years.